[Helicobacter pylori eradication: current status].
Ter Arkh
; 85(2): 73-5, 2013.
Article
em Ru
| MEDLINE
| ID: mdl-23653944
ABSTRACT
The paper gives an update on the efficiency of Helicobacter pylori eradication. Triple therapy (a proton pump inhibitor + clarithromycin + amoxicillin) therapy is shown to hold top positions as first-line therapy for H. pylori eradication as before. The leading second-line therapy regimens are quadruple and 10-day triple schemes including levofloxacin. This point of view is supported by the Russian Gastroenterology Association. To reduce an increase in H. pylori resistance to clarithromycin, it is advisable to use Klacid (generic name clarithromycin) in the eradication schemes.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Helicobacter pylori
/
Claritromicina
/
Quimioterapia Combinada
/
Inibidores da Bomba de Prótons
/
Erradicação de Doenças
/
Amoxicilina
Limite:
Humans
Idioma:
Ru
Ano de publicação:
2013
Tipo de documento:
Article